Cite

    Gilbert R. Thompson et al.. “Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes.” Atherosclerosis, vol. 243, no. 1, 2015, pp. 328–333. http://access.bl.uk/ark:/81055/vdc_100026679725.0x00005a